Nvidia Stock Drops on Weak Gaming Sales — Is It Time to Sell This Growth Stock?
Investors were disappointed when the chipmaker released its preliminary earnings results for the second quarter.
Mindfully Curated
Investors were disappointed when the chipmaker released its preliminary earnings results for the second quarter.
A climate change bill has officially passed the Senate and that’s boosting some stocks today.
The company’s stock rose steadily throughout the month.
The company’s top and bottom lines both declined considerably in the second quarter.
This oil-field services company reported a strong quarter and growing backlog.
The blood-disorder specialist sells itself in a deal with an enterprise value of around $5.4 billion.
The digital media technologist has already staged a solid recovery from the earnings-based plunge, but where will it go from here?
The UN labour agency, ILO, says it is becoming increasingly concerned about working conditions in Iraq, where temperatures have soared to 50 degrees Celsius in recent weeks.
The new legislation supporting electric vehicle sales is boosting the entire sector today.
Shares of the fintech disruptor were up ahead of the earnings report this afternoon.
Investors had two bits of good news today.
The freelance marketplace operator announced a significant round of layoffs, making it look like the company’s high-growth phase might be ending sooner than investors hoped.
These EV stocks are rising on news of potential government support — but could some other EV stocks do even better?
Investors appear to be increasingly focused on fundamental growth metrics in the crypto world.
The market is back in “risk-on” mode.
Expectations of decelerating inflation and solid peer earnings helped these SaaS all-stars rally to begin the week.
Is today’s jump in share price a signal to buy — or sell?
The UN sexual and reproductive health agency, UNFPA, is leading efforts to protect women and girls’ rights to give birth safely and live without gender-based violence, according to a statement issued on Monday.
The biotech’s Q2 financial results are concerning investors today.